$ARTL News

Artelo Biosciences Files Prospectus To Offer Up To $6.53M In Common Stock Via H.C. Wainwright

Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results

Artelo Biosciences Q1 EPS $(4.00) Misses $(1.57) Estimate

Artelo Biosciences Files Prospectus For Offering $75M Mixed Shelf

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development

Artelo Biosciences Collaborates With ScienceMachine Over Development Of Its Fatty Acid-Binding Protein 5 Inhibitor Platform

What's Behind The Rise In Artelo Biosciences Stock?

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

Artelo shares are trading higher after the company announced the publication of a peer‑reviewed article titled "Evaluating fatty acid-binding protein 5 (FABP5) as a therapeutic target for pain management" in the European Journal of Pain.

Artelo shares are trading higher after the company announced the publication of a peer‑reviewed article titled "Evaluating fatty acid-binding protein 5 (FABP5) as a therapeutic target for pain management" in the European Journal of Pain.

Artelo Biosciences Announces Publication Of Peer‑Reviewed Article On FABP5 As Therapeutic Target For Pain Management In European Journal Of Pain

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements

ARTL stock has given up its prior gain. Artelo Biosciences shares were trading higher after the company announced it regained Nasdaq compliance.

Artelo Biosciences shares are trading higher after the company announced it regained Nasdaq compliance.

Artelo Biosciences Regains Nasdaq Compliance

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Artelo Biosciences Announces $11M Private Placement Of 3,188,407 Shares Of Common Stock And Warrants To Purchase Up To 6,376,814 Shares Of Common Stock, At A Combined Purchase Price Of $3.45

Artelo Biosciences Shares Halted On Circuit Breaker To The Downside, Stock Now Up 238.56%

Artelo Biosciences Stock Soars After Withdrawing SEC Filing